- RSV is a common virus that infects the respiratory tract. It’s transmissible via respiratory droplets and is one of the three most threatening respiratory viruses this season as non-pharmacologic measures have by-and-large been dropped. It can be particularly severe for infants younger than 6 months or those who are compromised or elderly.
- The virus typically spikes in January, but RSV surged early this year with the overall shifting viral landscape during the pandemic. As of mid-November, RSV activity was high in all regions of the US, with a particularly burdensome number of hospitalizations.
- According to the American Academy of Pediatrics, palivizumab, a monoclonal antibody to prevent severe lung infection, may be given to eligible infants throughout the 2022-23 RSV season.